Envision Report

Published January 8, 2018

Drug Discovery Market – Size, Outlook, Trends, and Forecasts (2018 – 2024)

Download Free Sample Report!

The global drug discovery market is projected to grow from $33998 million in 2018 to $68684 million by 2024 growing at a CAGR of 9.20% during the forecast period.  Drug discovery is a process of inventing a new medication in the field of pharmaceuticals, biotechnology and pharmacology. It is a complicated, lengthy and expensive process. Though advanced technologies are available, the success rate of drug discovery is meagre and the time involved is relatively high.

Global Drugs Discovery Market Share:

Compared to the past years, Global Drugs Market has undergone a predominant change in the markets. Pharmaceutical Services is expected to have the highest growth rate when compared with other segments.

Global Drugs Discovery Market Size:

Geographically, the global drug discovery outsourcing market can be categorised into North America, Europe, Asia-Pacific and rest of the world regions. North America currently holds the most significant share in this market and is followed by Europe due to the existence and early adoption of highly developed technologies and supportive economy. Asia-Pacific is a promising market for drug discovery outsourcing and is expected to undergo rapid market growth.

Global Drugs Discovery Market Growth:

High prevalence of health disorders such as genetic disorders, nervous system disorders, diabetes, cardiovascular diseases and others; rising demand for novel drug discovery technologies owing to the growing population; and advancements in the field of biotechnology, molecular biology and genomics. Moreover, the populated pipeline for novel drugs coupled with the patent expiry of several other drugs and increased expenditure on healthcare is also driving the market growth.

Global Drugs Discovery Market Industry Analysis:

The drug discovery market by the technology is segmented into QPCR, DNA microarrays, protein microarrays, high-throughput screening, mass spectrometry, etc. By service, The market is segmented into Pharmaceutical Services, Drug Metabolism and Pharmacokinetics (DMPK) Services, etc. By End-users, The market is segmented into Biotech companies, Pharmaceutical companies, etc.

Global Drugs Discovery Market Outlook:

Massive investments, a shift of market branded drugs to generic drugs and delayed processing of government regulations are hampering the market growth. The governments in North American countries such as the U.S. and Canada have also formulated encouraging policies for the investors to research and develop new drugs. The demand for drug discovery technologies in the region of North America gains high-income population, collectively promising healthy potential returns on investments due to the high adoption rate of new technologies.

Global Drugs Discovery Market Trends:

Merck Receives an FDA Approval for ISENTRESS, in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection in Newborns Weighing at Least 2 kg. Jubilant Biosys Ltd. announced that they successfully achieved an early stage milestone related to a collaborative program with Sanofi in Frankfurt, Germany focused on metabolic disorders.

Global Drugs Discovery Market Research report includes:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis through industry value chain analysisPorter’s fivePESTLESWOT analysis, and Y-o-Y analysis.
  • Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on YearOnYear
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by the analyst to the individual and organisation to have the better foothold in the market.
  • Identify the latest developments, market shares and strategies that are employed by the major market players, such as
  • Jubilant Biosys
  • Roche Holding AG
  • Sanofi
  • Infosys
  • Covance

Table of contents:

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of  the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2 Porter’s Five Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 Pestle Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threat

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5 Market Segmentation Analysis        

Chapter 6 Market Segmentation, By Technology 

     6.1 Protein and Nucleic acid isolation

6.2 Chromatography

6.3 Gel Electrophoresis

6.4 Mass Spectrometry

6.5 High Throughput Screening

6.6 Protein Microarrays

6.7 DNA Microarrays

6.8 QPCR

6.9 Others

Chapter 7 Market Segmentation, By Service 

7.1 Biological Services

7.2 Chemical Services

7.3 Pharmaceutical Services

7.4 Drug Metabolism and Pharmacokinetics (DMPK) Services

Chapter 8 Market Segmentation, By End Users 

8.1 Biopharmaceuticals

8.2 Biotech companies

8.3 Pharmaceutical companies

8.4 Research Institutes

8.5 Others

Chapter 9 Market Segmentation, By Geography

9.1 North America

9.1.1 Introduction

9.1.2 United States

9.1.3 Canada

9.1.4 Mexico

9.1.5 Others

9.2 Europe

9.2.1 Introduction

9.2.2 U.K

9.2.3 Spain

9.2.4 Italy

9.2.5 France

9.2.6 Russia

9.2.7 Others

9.3 Asia-Pacific

9.3.1 Introduction

9.3.2 China

9.3.3 India

9.3.4 Japan

9.3.5 Australia

9.3.6 Others

9.4 South  America

9.4.1 Introduction

9.4.2 Brazil

9.4.3 Argentina

9.4.4 Others

9.5 The Middle East & Africa

9.5.1 Introduction

9.5.2 South Africa

9.5.3 Others

Chapter 10 Competitive Landscape

10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

10.2  Market Share Analysis

10.3 Strategies Adopted By Top Companies

Chapter 11 Company Profiles 

11.1. Roche Holding AG

11.1.1. Company Overview

11.1.2. Financial Performance

11.1.3. Product Benchmarking

11.1.4. Strategic Initiative

11.2. Merck & Co. Inc

11.3. Eli Lily

11.4. GlaxoSmithKline LLC

11.5. Pfizer, Inc

11.6. AstraZeneca PLc

11.7. Johnson and Johnson

11.8. Sanofi

11.9. Jubilant Biosys

11.10. Bayer AG

11.11. Covance

11.12. Boehringer Ingelheim GmBh

11.13. Albany Molecular Research Inc.

11.14. Charles River Laboratories

11.15. Infosys

Chapter 12 Market Estimates and Forecast

12.1   Market Estimates and Forecast 2018-2024(USD Million)

12.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)

12.1.2 Market Estimation and Forecast by Service 2018-2024 (USD Million)

12.1.3 Market Estimation and Forecast by End Users 2018-2024 (USD Million)

12.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)

Chapter 13 Market Insights

13.1 Insights of Industry Experts

13.2 Analyst Opinion (Market Understanding)

13.3 Investment Opportunities

Chapter 14 Appendix

14.1 List of Tables

14.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.